A systematic review of treatments for Clostridium difficile infection (CDI) yesterday in Infection Control and Hospital Epidemiology concludes that the most cost-effective treatment remains unclear.
Italian scientists this week reported detecting the MCR-1 colistin-resistance gene in 26 Escherichia coli isolates among more than 19,000 Enterobacteriaceae that they tested as part of surveillance efforts in Romagna in northern Italy.
The United States, Brazil, Argentina, and now Canada, have all reported cases of cephalosporin-resistant gonorrhea, according to the latest situation report published by the Pan American Health organization (PAHO).
The Georgia Department of Public Health (GDPH) tuberculosis program is assisting with the investigation of two confirmed multidrug-resistant tuberculosis (MDR-TB) cases in the northeastern part of the state, according to Nancy Nydam, a communications official with the GDPH.
A large longitudinal study of an elderly population in Taiwan found that flu vaccination reduced the risk of tuberculosis (TB) infection by 18%. Earlier studies, including animal ones, have hinted that flu vaccination might protect against a range of pathogens, including TB, due to activation of T-cell mediated immunity. A team from Taiwan reported the findings yesterday in Emerging Infectious Diseases.
Yesterday and today the Saudi Arabian Ministry of Health (MOH) announced four new cases of MERS-CoV in different cities across the country, including one involving a health worker.
The Centers for Disease Control and Prevention (CDC), in an update on an ongoing outbreak of multi-drug resistant Campylobacter infections linked to puppies sold in pet shops today, confirmed 30 new cases reported since the last outbreak update published on Oct 30.
An international team of researchers has found that a re-engineered rapid molecular test for detection of tuberculosis (TB) is more sensitive than the current test but less specific, according to a study yesterday in The Lancet Infectious Diseases.
The results of a small phase 1 clinical trial show that an activated charcoal product helped protect the gut microbiome in volunteers treated with moxifloxacin, French researchers report in the Journal of Infectious Diseases.
Commitments included scaling up research investments and building a framework for country accountability on steps to reach the declaration's goals.
